Analysis of efficacy and prognostic factors for second-line chemotherapy in gemcitabine-refractory advanced biliary tract cancer

被引：0
|
作者：
Okano, N. [1 ]
Kawai, K. [1 ]
Kobayashi, T. [1 ]
Naruge, D. [1 ]
Nagashima, F. [1 ]
Furuse, J. [1 ]
机构：
[1] Kyorin Univ Hosp, Med Oncol, Mitaka, Tokyo, Japan
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
10.1093/annonc/mdw371.94
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
702P
引用
收藏
页数：1
相关论文
共 50 条
  • [1] An Analysis of a Second-Line S-1 Monotherapy for Gemcitabine-Refractory Biliary Tract Cancer
    Katayose, Yu
    Ohtsuka, Hideo
    Kitamura, Yo
    Masuda, Kunihiro
    Nakagawa, Kei
    Yamamoto, Kuniharu
    Yoshida, Hiroshi
    Onogawa, Tohru
    Motoi, Fuyuhiko
    Naitoh, Takeshi
    Rikiyama, Toshiki
    Egawa, Shin-ichi
    Unno, Michiaki
    [J]. HEPATO-GASTROENTEROLOGY, 2012, 59 (115) : 691 - 695
  • [2] Multivariate prognostic factors analysis for second-line chemotherapy in advanced biliary tract cancer
    Fornaro, L.
    Cereda, S.
    Aprile, G.
    Di Girolamo, S.
    Santini, D.
    Silvestris, N.
    Lonardi, S.
    Leone, F.
    Milella, M.
    Vivaldi, C.
    Belli, C.
    Bergamo, F.
    Lutrino, S. E.
    Filippi, R.
    Russano, M.
    Vaccaro, V.
    Brunetti, A. E.
    Rotella, V.
    Falcone, A.
    Barbera, M. A.
    Corbelli, J.
    Fasola, G.
    Aglietta, M.
    Zagonel, V.
    Reni, M.
    Vasile, E.
    Brandi, G.
    [J]. BRITISH JOURNAL OF CANCER, 2014, 110 (09) : 2165 - 2169
  • [3] Multivariate prognostic factors analysis for second-line chemotherapy in advanced biliary tract cancer
    L Fornaro
    S Cereda
    G Aprile
    S Di Girolamo
    D Santini
    N Silvestris
    S Lonardi
    F Leone
    M Milella
    C Vivaldi
    C Belli
    F Bergamo
    S E Lutrino
    R Filippi
    M Russano
    V Vaccaro
    A E Brunetti
    V Rotella
    A Falcone
    M A Barbera
    J Corbelli
    G Fasola
    M Aglietta
    V Zagonel
    M Reni
    E Vasile
    G Brandi
    [J]. British Journal of Cancer, 2014, 110 : 2165 - 2169
  • [4] Analysis of Clinical Predictive Factors Affecting the Outcome of Second-Line Chemotherapy for Gemcitabine-Refractory Advanced Pancreatic Cancer
    Lee, Jeung Eun
    Lee, Hee Seung
    Chung, Moon Jae
    Park, Jeong Youp
    Park, Seung Woo
    Song, Si Young
    Bang, Seungmin
    [J]. GUT AND LIVER, 2020, 14 (01) : 135 - 143
  • [5] Oral chemotherapy for second-line treatment in patients with gemcitabine-refractory advanced pancreatic cancer
    Park, Se Jun
    Kim, Hyunho
    Shin, Kabsoo
    Lee, Myung Ah
    Hong, Tae Ho
    [J]. WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2019, 11 (11) : 1021 - 1030
  • [6] Prognostic factor analysis of second-line chemotherapy in advanced biliary tract cancer
    Lee, Sang-Cheol
    Kim, Kyoungha
    Kim, Hanjo
    Kim, Hyun Jung
    Kim, Se Hyung
    Bae, Sang-Byung
    Kim, Chan Kyu
    Lee, Namsu
    Lee, Kyu Taek
    Park, Sung Kyu
    Won, Jong-Ho
    Yun, Jina
    Hong, Dae Sik
    Park, Hee Sook
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [7] Oral chemotherapy for second-line treatment in patients with gemcitabine-refractory advanced pancreatic cancer
    Se Jun Park
    Hyunho Kim
    Kabsoo Shin
    Myung Ah Lee
    Tae Ho Hong
    [J]. World Journal of Gastrointestinal Oncology, 2019, (11) : 1021 - 1030
  • [8] Second-line chemotherapy in biliary tract cancer: Outcome and prognostic factors
    Schweitzer, Nora
    Kirstein, Martha M.
    Kratzel, Anna-Maria
    Mederacke, Young-Seon
    Fischer, Mareike
    Manns, Michael P.
    Vogel, Arndt
    [J]. LIVER INTERNATIONAL, 2019, 39 (05) : 914 - 923
  • [9] Prognostic Factors for the Selection of Patients Eligible for Second-Line Chemotherapy in Advanced Biliary Tract Cancer
    Kang, Eun Joo
    Choi, Yoon Ji
    Kim, Jung Sun
    Park, Kyong Hwa
    Oh, Sang Chul
    Seo, Jae Hong
    Kim, Hong Jun
    Kang, Ka-Won
    Yu, Eun Sang
    Shin, Sang W.
    Kim, Yeul H.
    Kim, Jun Suk
    [J]. CHEMOTHERAPY, 2014, 60 (02) : 91 - 98
  • [10] Paclitaxel as second-line chemotherapy in patients with gemcitabine-refractory pancreatic cancer: a retrospective study
    Maeda, Shimpei
    Motoi, Fuyuhiko
    Onogawa, Tohru
    Morikawa, Takanori
    Shigeru, Ottomo
    Sakata, Naoaki
    Takadate, Tatsuyuki
    Naitoh, Takeshi
    Rikiyama, Toshiki
    Katayose, Yu
    Egawa, Shinichi
    Unno, Michiaki
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2011, 16 (05) : 539 - 545
12345